Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)
Scholar Rock shares dropped 11.26% after the FDA cited Catalent Indiana with an official action indicated classification impacting Scholar Rock's biologics license application.
2 Articles
2 Articles
Why Scholar Rock Stock Got Socked on Monday @themotleyfool #stocks $SRRK $^GSPC
Key PointsA third-party manufacturing facility has apparently been flagged by the FDA.The plant is owned by pharmaceutical industry peer Novo Nordisk.10 stocks we like better than Scholar Rock › A potential delay in an important submission was the news item driving Scholar Rock's (NASDAQ: SRRK) share price down as the trading week kicked off. On Monday, the biotech's shares fell by more than 13% as a result, contrasting unfavorably with the 1.6%…
Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)
Scholar Rock Holding Inc. (NASDAQ:SRRK) stock is falling on Monday with a session volume of 8.19 million versus the average volume of 2.08 million, as per data from Benzinga Pro. In a press release on Monday, the company stated that on Friday, October 10, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Catalent Indiana, LLC, a subsidiary of Novo Nordisk A/S (NYSE:NVO). The FDA inspected the facility in July and determined that t…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium